Correction announcement from Al Hammadi Holding in regard to announce its Annual Financial results for the period ending on 2025-12-31

1) Exceptional Gains: The company realized non-recurring gains of 55.27 million Saudi Riyals from the sale of a vacant land plot in Al Rayan district of Riyadh during the second quarter of 2024.

2) Decrease in Selling and Marketing Expenses: Selling and marketing expenses decreased from 9.26 million Saudi Riyals in 2023 to 4.19 million Saudi Riyals in 2024. This is due to lower sales from the subsidiary company.

3) Growth in Financing Income: Financing income, which amounted to 6.14 million Saudi Riyals during 2024, reflecting an increase in the company's cash balance during the year and improved collection efficiency.

4) Increase in Share of Profits from the Associate Company: The share of profits from the associate company increased to 6.72 million Saudi Riyals, compared to 4.18 million Saudi Riyals in the previous year.

5) Decrease in Zakat Expense: The Zakat expense for 2024 decreased to 15.88 million Saudi Riyals, compared to 17.62 million Saudi Riyals for 2023. This is due to a decrease in the estimated Zakat base for the current year.

1) Recording non-recurring gains in the previous year (2024) amounting to 55.27 million Saudi Riyals , resulting from the sale of a land plot in the Al-Rayan district of Riyadh.

2) Increase in operating and staff costs due to the Group’s strategic direction to expand its service scope within the medical services and pharmaceutical retail sectors.

3) Rise in General & Administrative and Selling & Marketing expenses by a total of 19.64 million Saudi Riyals, supporting the strategy to diversify services and achieve sustainable growth in future revenues.

4) Increase in Expected Credit Loss (ECL) provisions, which reached 21.11 million Saudi Riyals in 2025 compared to 9.07 million Saudi Riyals in the previous year. This is due to delays in collecting certain receivables from some of the company’s major clients.

5) Recording a goodwill impairment loss resulting from investments in subsidiaries, amounting to SAR 4.30 million during the year 2025.

6) Decrease in finance income to 3.77 million Saudi Riyals , resulting from the commitment to fund and accelerate construction works at Al-Hammadi Hospital (Al-Olaya), which necessitated the utilization of a portion of the company’s cash balances to ensure timely completion."